Back to Search
Start Over
Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2.
- Source :
- BMC Infectious Diseases; 8/26/2024, Vol. 24 Issue 1, p1-17, 17p
- Publication Year :
- 2024
-
Abstract
- Background: The immunological background responsible for the severe course of COVID-19 and the immune factors that protect against SARS-CoV-2 infection are still unclear. The aim of this study was to investigate immune system status in persons with high exposure to SARS-CoV-2 infection. Methods: Seventy-one persons employed in the observation and infectious diseases unit were qualified for the study between November 2020 and October 2021. Symptomatic COVID-19 was diagnosed in 35 persons. Anti-SARS-CoV-2 antibodies were also found in 8 persons. Peripheral blood mononuclear cells subpopulations were analyzed by flow cytometry, and the concentrations of cytokines and anti-SARS-CoV-2 antibodies were determined by ELISA. Results: The percentages of cytotoxic T lymphocytes (CTLs), CD28<superscript>+</superscript> and T helper (Th) cells with invariant T-cell receptors were significantly higher in persons with symptomatic COVID-19 than in those who did not develop COVID-19' symptoms. Conversely, symptomatic COVID-19 persons had significantly lower percentages of: a) CTLs in the late stage of activation (CD8<superscript>+</superscript>/CD95<superscript>+</superscript>), b) NK cells, c) regulatory-like Th cells (CD4<superscript>+</superscript>/CTLA-4<superscript>+</superscript>), and d) Th17-like cells (CD4<superscript>+</superscript>/CD161<superscript>+</superscript>) compared to asymptomatic COVID-19' persons. Additionally, persons with anti-SARS-CoV-2 antibodies had a significantly higher lymphocyte count and IL-6 concentration than persons without these antibodies. Conclusion: Numerous lymphocyte populations are permanently altered by SARS-CoV-2 infection. High percentages of both populations: NK cells—as a part of the non-specific response, and T helper cells' as those regulating the immune response, could protect against the acute COVID-19 symptoms development. Understanding the immune background of COVID-19 may improve the prevention of this disease by identifying people at risk of a severe course of infection. Trial registration: This is a retrospective observational study without a trial registration number. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14712334
- Volume :
- 24
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- BMC Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 179257736
- Full Text :
- https://doi.org/10.1186/s12879-024-09772-5